Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M79.5Revenue $M13.2Net Margin (%)-104.1Altman Z-Score0.2
Enterprise Value $M83.6EPS $-0.2Operating Margin %-144.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.1Pre-tax Margin (%)-127.1Higher ROA y-yY
Price/Book2.210-y EBITDA Growth Rate %--Quick Ratio2.4Cash flow > EarningsY
Price/Sales6.45-y EBITDA Growth Rate %--Current Ratio3.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-18.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-31.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M77.9ROIC % (ttm)-54.1Gross Margin Increase y-yN

Gurus Latest Trades with NEPT

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

NEPT is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NEPT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Montgomery, Adrian TaylorDirector 2014-12-03Buy11,000$2.21-53.85view
Godin, AndrSenior Officer 2014-11-12Buy3,000$2.15-52.56view
Lemieux, PierreDirector or Senior Officer of Insider or Subsidiar 2014-11-12Buy5,000$2.19-53.42view
Godin, AndrSenior Officer 2014-11-11Buy8,000$2.12-51.89view
Ripplinger, JohnSenior Officer 2014-11-11Buy3,550$2.12-51.89view
Turcotte, MarioSenior Officer 2014-11-11Buy6,870$2.14-52.34view
Fitzgibbon, PierreDirector 2014-11-10Buy37,500$2.09-51.2view
Huart, BenoîtDirector 2014-11-10Buy7,000$2.03-49.75view
Lauzon, ClaudieSenior Officer 2014-11-10Buy2,400$2.08-50.96view
Le Bel, DominiqueSenior Officer 2014-11-10Buy10,000$2.01-49.25view

Press Releases about NEPT :

Quarterly/Annual Reports about NEPT:

    News about NEPT:

    Articles On GuruFocus.com
    What Drives St. Jude Medical to Be More Diversified? Apr 30 2014 

    More From Other Websites
    Acasti Announces Share-for-Debt Feb 05 2016
    Neptune Tech reports 3Q loss Jan 12 2016
    Neptune Tech reports 3Q loss Jan 12 2016
    Acasti Announces Third Quarter Results Jan 12 2016
    Neptune Announces Third Quarter Results Jan 12 2016
    Neptune Acquires Biodroga, Creating New Growth Platform Jan 07 2016
    Acasti & Neptune Enter Into Transactional Arrangement & Sign Operational Agreements Jan 07 2016
    Neptune Acquires Biodroga, Creating New Growth Platform Jan 07 2016
    Neptune to Hold Conference Call to Discuss Third Quarter Results Jan 05 2016
    Acasti Provides Update on CaPre® Development Pathway Dec 16 2015
    NEPTUNE TECHNOLOGIES & BIORESSOURCES INC. Financials Dec 08 2015
    Neptune Announces Preliminary Q3 Results Dec 07 2015
    Neptune Announces Preliminary Q3 Results Dec 07 2015
    Acasti Granted Composition & Use Patent in Japan, Taiwan and Mexico Dec 01 2015
    ow.ly/Uq9vG Nov 10 2015
    Neptune Technologies & Bioresources, Inc. Earnings Q2, 2016 Oct 19 2015
    Neptune Announces Second Quarter Results Oct 15 2015
    Neptune Tech reports 2Q loss Oct 14 2015
    Neptune Tech reports 2Q loss Oct 14 2015
    Neptune Announces Director Election Results Aug 07 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK